To administratively DE-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552 (a), in preparation for september 30, 2026, closing of the period of…
Ended Awarded Last action
- Contract number
- 75N91021F00079
- Awardee
-
Astrix Technology LLC UEI NRVNN8E6NCK4
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- -$11,861
Award facts
- Contract value 0% obligated
-
- $113,057.28 Current, with exercised options
- $381,921.48 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Labor Hours
- Place of performance
- Red Bank, NJ, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$11,861 | |
| Original award | $124,918 |
About this award
This contract award represents a Blanket Purchase Agreement (BPA) call issued by the National Cancer Institute (NCI), a component of the National Institutes of Health, to Astrix Technology LLC for scientific support services. Valued at $381,921.48 with an ultimate completion date of September 19, 2024, the award was made on September 20, 2021, under the General Services Administration's Multiple Award Schedule (MAS) contract vehicle with no set-aside designations. The work was performed in Red Bank, New Jersey, with compensation structured on a labor hours pricing model. The award notice indicates administrative de-obligation of unexpended and expiring fiscal year 2021 funding in preparation for the September 30, 2026 closing of the period of availability for these funds, as required by 31 U.S.C. Section 1552(a).
Astrix Technology LLC, headquartered in Red Bank, New Jersey, is a specialized staffing and scientific support services provider with extensive experience supporting NIH institutes and centers since its SAM.gov registration in May 2002. The company maintains a $20 million single-award BPA with the NIH's Office of Logistics and Acquisition Operations (through May 31, 2025) under which this NCI call was issued, enabling rapid acquisition of specialized scientific and administrative personnel across multiple NIH institutes without conducting individual competitions. Astrix Technology delivers a range of scientific, technical, and administrative support roles including researchers, clinical research nurses, laboratory technicians, biostatisticians, and program managers, with this specific NCI engagement representing one of numerous task orders executed under the broader NIH BPA vehicle.
Description
To administratively DE-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552 (a), in preparation for september 30, 2026, closing of the period of availability of these fiscal year funds.
Quick answers
Who was awarded contract 75N91021F00079?
75N91021F00079 was awarded to Astrix Technology LLC by National Cancer Institute (National Institutes of Health) on September 20, 2021.
How much is contract 75N91021F00079 worth?
The government has obligated -$11,861 on 75N91021F00079. Its current value, with exercised options, is $113,057. Its potential value, with all options, is $381,921.
Is contract 75N91021F00079 an order under another contract?
Yes. 75N91021F00079 is a BPA call under GS07F147DA-HHSN261201700002B, a blanket purchase agreement, on Multiple Award Schedule (MAS).
Was contract 75N91021F00079 competed?
The extent of competition for 75N91021F00079 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award